164 related articles for article (PubMed ID: 18079253)
1. Natural history of stage I lung cancer.
Reich J; Asaph J
Chest; 2007 Dec; 132(6):2062; author reply 2062-3. PubMed ID: 18079253
[No Abstract] [Full Text] [Related]
2. Natural history of stage I non-small cell lung cancer: implications for early detection.
Raz DJ; Zell JA; Ou SH; Gandara DR; Anton-Culver H; Jablons DM
Chest; 2007 Jul; 132(1):193-9. PubMed ID: 17505036
[TBL] [Abstract][Full Text] [Related]
3. Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
Lynch TJ; Bogart JA; Curran WJ; DeCamp MM; Gandara DR; Goss G; Henschke CI; Jett JR; Johnson BE; Kelly KL; Le Chevalier T; Mulshine JL; Scagliotti GV; Schiller JH; Shaw A; Thatcher N; Vokes EE; Wood DE; Hart C
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4981s-4983s. PubMed ID: 16000599
[No Abstract] [Full Text] [Related]
4. Thoracic inspirations: advances in the diagnosis, staging, and treatment of non-small-cell lung cancer.
Toloza EM
Cancer Control; 2014 Jan; 21(1):4-5. PubMed ID: 24357735
[No Abstract] [Full Text] [Related]
5. [Non-small cell lung cancer].
Yoshimura A; Niitani H
Ryoikibetsu Shokogun Shirizu; 1994; (4):100-3. PubMed ID: 8007089
[No Abstract] [Full Text] [Related]
6. Non-small cell lung cancer.
Ettinger DS; Akerley W; Bepler G; Blum MG; Chang A; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Jahan T; Jahanzeb M; Johnson DH; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Le QT; Lennes IT; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Simon GR; Swanson SJ; Wood DE; Yang SC;
J Natl Compr Canc Netw; 2010 Jul; 8(7):740-801. PubMed ID: 20679538
[No Abstract] [Full Text] [Related]
7. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Crinò L; Weder W; van Meerbeeck J; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v103-15. PubMed ID: 20555058
[No Abstract] [Full Text] [Related]
8. Practice guidelines for non-small cell lung cancer.
Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
[No Abstract] [Full Text] [Related]
9. Non-small cell lung cancer: issues in diagnosis, staging and treatment.
Harwood KV
Semin Oncol Nurs; 1987 Aug; 3(3):183-93. PubMed ID: 3039637
[No Abstract] [Full Text] [Related]
10. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
D'Addario G; Felip E;
Ann Oncol; 2008 May; 19 Suppl 2():ii39-40. PubMed ID: 18456762
[No Abstract] [Full Text] [Related]
11. Early stage lung cancer: progress in the last 40 years [corrected].
Novello S; Asamura H; Bazan J; Carbone D; Goldstraw P; Grunenwald D; Ricardi U; Vansteenkiste J
J Thorac Oncol; 2014 Oct; 9(10):1434-42. PubMed ID: 25170646
[No Abstract] [Full Text] [Related]
12. Non-small-cell lung cancer: then and now.
Schiller JH; Gandara DR; Goss GD; Vokes EE
J Clin Oncol; 2013 Mar; 31(8):981-3. PubMed ID: 23401450
[No Abstract] [Full Text] [Related]
13. [Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].
Goeckenjan G; Sitter H; Thomas M; Branscheid D; Flentje M; Griesinger F; Niederle N; Stuschke M; Blum T; Deppermann KM; Ficker JH; Freitag L; Lübbe AS; Reinhold T; Späth-Schwalbe E; Ukena D; Wickert M; Wolf M; Andreas S; Auberger T; Baum RP; Baysal B; Beuth J; Bickeböller H; Böcking A; Bohle RM; Brüske I; Burghuber O; Dickgreber N; Diederich S; Dienemann H; Eberhardt W; Eggeling S; Fink T; Fischer B; Franke M; Friedel G; Gauler T; Gütz S; Hautmann H; Hellmann A; Hellwig D; Herth F; Heussel CP; Hilbe W; Hoffmeyer F; Horneber M; Huber RM; Hübner J; Kauczor HU; Kirchbacher K; Kirsten D; Kraus T; Lang SM; Martens U; Mohn-Staudner A; Müller KM; Müller-Nordhorn J; Nowak D; Ochmann U; Passlick B; Petersen I; Pirker R; Pokrajac B; Reck M; Riha S; Rübe C; Schmittel A; Schönfeld N; Schütte W; Serke M; Stamatis G; Steingräber M; Steins M; Stoelben E; Swoboda L; Teschler H; Tessen HW; Weber M; Werner A; Wichmann HE; Irlinger Wimmer E; Witt C; Worth H; ;
Pneumologie; 2011 Aug; 65(8):e51-75. PubMed ID: 21830177
[No Abstract] [Full Text] [Related]
14. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
Felip E; Stahel RA; Pavlidis N;
Ann Oncol; 2005; 16 Suppl 1():i28-9. PubMed ID: 15888743
[No Abstract] [Full Text] [Related]
15. [Prevention, diagnosis, therapy, and follow-up of lung cancer].
Goeckenjan G; Sitter H; Thomas M; Branscheid D; Flentje M; Griesinger F; Niederle N; Stuschke M; Blum T; Deppermann KM; Ficker JH; Freitag L; Lübbe AS; Reinhold T; Späth-Schwalbe E; Ukena D; Wickert M; Wolf M; Andreas S; Auberger T; Baum RP; Baysal B; Beuth J; Bickeböller H; Böcking A; Bohle RM; Brüske I; Burghuber O; Dickgreber N; Diederich S; Dienemann H; Eberhardt W; Eggeling S; Fink T; Fischer B; Franke M; Friedel G; Gauler T; Gütz S; Hautmann H; Hellmann A; Hellwig D; Herth F; Heussel CP; Hilbe W; Hoffmeyer F; Horneber M; Huber RM; Hübner J; Kauczor HU; Kirchbacher K; Kirsten D; Kraus T; Lang SM; Martens U; Mohn-Staudner A; Müller KM; Müller-Nordhorn J; Nowak D; Ochmann U; Passlick B; Petersen I; Pirker R; Pokrajac B; Reck M; Riha S; Rübe C; Schmittel A; Schönfeld N; Schütte W; Serke M; Stamatis G; Steingräber M; Steins M; Stoelben E; Swoboda L; Teschler H; Tessen HW; Weber M; Werner A; Wichmann HE; Irlinger Wimmer E; Witt C; Worth H;
Pneumologie; 2010 Mar; 64 Suppl 2():e1-164. PubMed ID: 20217630
[No Abstract] [Full Text] [Related]
16. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
[No Abstract] [Full Text] [Related]
17. Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.
Toschi L; Cappuzzo F; Jänne PA
Ann Oncol; 2007 Jul; 18 Suppl 9():ix150-5. PubMed ID: 17631569
[No Abstract] [Full Text] [Related]
18. Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer.
Ohri N; Piperdi B; Garg MK; Bodner WR; Gucalp R; Perez-Soler R; Keller SM; Guha C
Lung Cancer; 2015 Jan; 87(1):23-7. PubMed ID: 25468149
[TBL] [Abstract][Full Text] [Related]
19. Rapid biomarker testing for improved clinical decision-making in nonsmall cell lung cancer.
Kaplan EH
MLO Med Lab Obs; 2017 Jun; 49(6):12-4, 16-8. PubMed ID: 29952196
[No Abstract] [Full Text] [Related]
20. Oligometastatic non-small cell lung cancer: Where do we go next?
Malik N; Palma D
Lung Cancer; 2017 Apr; 106():145-147. PubMed ID: 28062090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
